Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7474 427
20 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Respond swiftly to phase 2 of Lord Darzi’s review

Pharmacists are urged to respond to the second phase of Lord Darzi’s review of the NHS in England by various national pharmacy bodies. The second phase of “Our NHS, our future” aims to capture the views of local people and frontline health professionals.

The pharmacy bodies believe that the most powerful advocates for pharmacy are patients. “Pharmacists should encourage their customers to participate in this exercise — especially those who have experienced enhanced pharmaceutical care — so they can share their real-life experience of pharmacy services,” said a spokesman.

They are encouraging pharmacists to act quickly since local consultations are already under way. These consultations are being led by strategic health authorities, which will establish groups of NHS and social care staff to discuss the vision for maternity services, staying healthy, children’s health, planned care, acute care, mental health, long-term conditions and end-of-life care.

Details of local meetings can be found on the internet. Comments can also be e-mailed to ourNHS@dh.gsi.gov.uk. Lord Darzi has already completed his review of services in London.

The pharmacy bodies believe that the consultation provides a platform for pharmacists to reinforce their role and accessibility as a service provider in primary care. It also gives an opportunity for hospital and primary care pharmacists to contribute their views on the above, or more general, issues.

The pharmacy bodies — the Royal Pharmaceutical Society, the Pharmaceutical Services Negotiating Committee, the National Pharmacy Association, the Primary Care Pharmacists’ Association, the Company Chemists’ Association, the Association of Independent Multiple Pharmacies and the Guild of Healthcare Pharmacists — are taking action at a national level. They plan to write to Lord Darzi to outline their views, ask for a meeting to discuss the challenges around pharmacy engagement and seek input into Lord Darzi’s advisory board.

Back to Top


©The Pharmaceutical Journal